Skip to content
TT
Company

Updated:

TCR2 THERAPEUTICS INC.

TCR2 THERAPEUTICS INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001750019, and its reported industry...

Overview

TCR2 THERAPEUTICS INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001750019, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2023-03-23, it reported net income of USD -151,822,000; total assets of USD 208,236,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
TCR2 THERAPEUTICS INC.
Classification
Company
Industry (SIC)
2836 — Biological Products, (No Diagnostic Substances)
Headquarters
Cambridge, MA, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0001750019

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2022USD-$151.8M$208.2M$32.7M-$101.5M
FY2021USD-$99.8M$323.4M$222.6M-$81.6M
FY2020USD-$67.1M$246.2M$94.2M-$56.7M
FY2019USD-$47.6M$168.5M$65.3M-$41.4M

Recent SEC filings

FormFiledPeriodFiling
8-KFORM 8-K
8-KFORM 8-K
8-K8-K
8-KFORM 8-K
10-Q10-Q
8-K8-K
10-K10-K
8-K8-K
8-K8-K
8-KFORM 8-K
8-K8-K
8-K8-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research TCR2 THERAPEUTICS INC. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

TCR2 THERAPEUTICS INC. | Cambridge Company | Altss